JACQUELINE MOUTON: Open Payments
NPI 1851558639 · CYPRESS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$518 in 29 payments from 9 companies in 2025. Trend: 2023 $528 · 2024 $727 · 2025 $518
Food & beverage: $518
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $175 |
| ABBVIE INC. | 3 | $85 |
| Exact Sciences Corporation | 5 | $77 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $71 |
| Organon LLC | 3 | $30 |
| Optinose US, Inc. | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
Products named: Ozempic, Cologuard Collection Kit, Wegovy, VRAYLAR, JARDIANCE, Xhance, LINZESS, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
